123 related articles for article (PubMed ID: 11554755)
21. Zebrafish Sox7 and Sox18 function together to control arterial-venous identity.
Pendeville H; Winandy M; Manfroid I; Nivelles O; Motte P; Pasque V; Peers B; Struman I; Martial JA; Voz ML
Dev Biol; 2008 May; 317(2):405-16. PubMed ID: 18377889
[TBL] [Abstract][Full Text] [Related]
22. APETALA1 and SEPALLATA3 interact with SEUSS to mediate transcription repression during flower development.
Sridhar VV; Surendrarao A; Liu Z
Development; 2006 Aug; 133(16):3159-66. PubMed ID: 16854969
[TBL] [Abstract][Full Text] [Related]
23. CHAMP, a novel cardiac-specific helicase regulated by MEF2C.
Liu ZP; Nakagawa O; Nakagawa M; Yanagisawa H; Passier R; Richardson JA; Srivastava D; Olson EN
Dev Biol; 2001 Jun; 234(2):497-509. PubMed ID: 11397016
[TBL] [Abstract][Full Text] [Related]
24. Calreticulin signals upstream of calcineurin and MEF2C in a critical Ca(2+)-dependent signaling cascade.
Lynch J; Guo L; Gelebart P; Chilibeck K; Xu J; Molkentin JD; Agellon LB; Michalak M
J Cell Biol; 2005 Jul; 170(1):37-47. PubMed ID: 15998798
[TBL] [Abstract][Full Text] [Related]
25. Mice null for sox18 are viable and display a mild coat defect.
Pennisi D; Bowles J; Nagy A; Muscat G; Koopman P
Mol Cell Biol; 2000 Dec; 20(24):9331-6. PubMed ID: 11094083
[TBL] [Abstract][Full Text] [Related]
26. Vascular defects in a mouse model of hypotrichosis-lymphedema-telangiectasia syndrome indicate a role for SOX18 in blood vessel maturation.
Downes M; François M; Ferguson C; Parton RG; Koopman P
Hum Mol Genet; 2009 Aug; 18(15):2839-50. PubMed ID: 19429912
[TBL] [Abstract][Full Text] [Related]
27. Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice.
Hosking B; François M; Wilhelm D; Orsenigo F; Caprini A; Svingen T; Tutt D; Davidson T; Browne C; Dejana E; Koopman P
Development; 2009 Jul; 136(14):2385-91. PubMed ID: 19515696
[TBL] [Abstract][Full Text] [Related]
28. BOP, a regulator of right ventricular heart development, is a direct transcriptional target of MEF2C in the developing heart.
Phan D; Rasmussen TL; Nakagawa O; McAnally J; Gottlieb PD; Tucker PW; Richardson JA; Bassel-Duby R; Olson EN
Development; 2005 Jun; 132(11):2669-78. PubMed ID: 15890826
[TBL] [Abstract][Full Text] [Related]
29. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation.
Ma K; Chan JK; Zhu G; Wu Z
Mol Cell Biol; 2005 May; 25(9):3575-82. PubMed ID: 15831463
[TBL] [Abstract][Full Text] [Related]
30. MEF2C transcription factor controls chondrocyte hypertrophy and bone development.
Arnold MA; Kim Y; Czubryt MP; Phan D; McAnally J; Qi X; Shelton JM; Richardson JA; Bassel-Duby R; Olson EN
Dev Cell; 2007 Mar; 12(3):377-89. PubMed ID: 17336904
[TBL] [Abstract][Full Text] [Related]
31. Analysis of SOX10 mutations identified in Waardenburg-Hirschsprung patients: Differential effects on target gene regulation.
Chan KK; Wong CK; Lui VC; Tam PK; Sham MH
J Cell Biochem; 2003 Oct; 90(3):573-85. PubMed ID: 14523991
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia.
Irrthum A; Devriendt K; Chitayat D; Matthijs G; Glade C; Steijlen PM; Fryns JP; Van Steensel MA; Vikkula M
Am J Hum Genet; 2003 Jun; 72(6):1470-8. PubMed ID: 12740761
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.
Grégoire S; Xiao L; Nie J; Zhang X; Xu M; Li J; Wong J; Seto E; Yang XJ
Mol Cell Biol; 2007 Feb; 27(4):1280-95. PubMed ID: 17158926
[TBL] [Abstract][Full Text] [Related]
34. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters.
Maeda T; Gupta MP; Stewart AF
Biochem Biophys Res Commun; 2002 Jun; 294(4):791-7. PubMed ID: 12061776
[TBL] [Abstract][Full Text] [Related]
35. SoxF genes: Key players in the development of the cardio-vascular system.
Francois M; Koopman P; Beltrame M
Int J Biochem Cell Biol; 2010 Mar; 42(3):445-8. PubMed ID: 19733255
[TBL] [Abstract][Full Text] [Related]
36. Requirement of the MADS-box transcription factor MEF2C for vascular development.
Lin Q; Lu J; Yanagisawa H; Webb R; Lyons GE; Richardson JA; Olson EN
Development; 1998 Nov; 125(22):4565-74. PubMed ID: 9778514
[TBL] [Abstract][Full Text] [Related]
37. Functional regulatory regions of human transcription factor MEF2C.
Janson CG; Chen Y; Li Y; Leifer D
Brain Res Mol Brain Res; 2001 Dec; 97(1):70-82. PubMed ID: 11744164
[TBL] [Abstract][Full Text] [Related]
38. Sox18 genetically interacts with VegfC to regulate lymphangiogenesis in zebrafish.
Cermenati S; Moleri S; Neyt C; Bresciani E; Carra S; Grassini DR; Omini A; Goi M; Cotelli F; François M; Hogan BM; Beltrame M
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1238-47. PubMed ID: 23520166
[TBL] [Abstract][Full Text] [Related]
39. Construction and functional analysis of novel dominant-negative mutant of human SOX18 protein.
Milivojevic M; Petrovic I; Kovacevic-Grujicic N; Popovic J; Mojsin M; Stevanovic M
Biochemistry (Mosc); 2013 Nov; 78(11):1287-92. PubMed ID: 24460943
[TBL] [Abstract][Full Text] [Related]
40. The transcription factor MEF2C is required for craniofacial development.
Verzi MP; Agarwal P; Brown C; McCulley DJ; Schwarz JJ; Black BL
Dev Cell; 2007 Apr; 12(4):645-52. PubMed ID: 17420000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
